Document is current

Any future updates will be listed below

Long-term efficacy and safety of interferon α-2a therapy in severe refractory ophthalmic Behcet’s disease

Crossref DOI link: https://doi.org/10.1007/s10067-016-3318-6

Published Online: 2016-05-27

Published Print: 2016-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark